270 related articles for article (PubMed ID: 25912114)
1. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.
Kiuchi MG; Chen S; Graciano ML; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
Int J Cardiol; 2015; 190():29-31. PubMed ID: 25912114
[No Abstract] [Full Text] [Related]
2. Improvement of the renal function after renal sympathetic denervation in refractory hypertensive patients with chronic kidney disease: possible predictors.
Kiuchi MG; Graciano ML; Chen S; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
Int J Cardiol; 2015 Nov; 199():10-2. PubMed ID: 26173167
[No Abstract] [Full Text] [Related]
3. Improvement of renal function after renal sympathetic denervation in CKD patients with controlled vs. uncontrolled hypertension.
Kiuchi MG; Chen S
Int J Cardiol; 2016 Nov; 223():494-496. PubMed ID: 27544613
[No Abstract] [Full Text] [Related]
4. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
[TBL] [Abstract][Full Text] [Related]
5. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
Symplicity HTN-1 Investigators
Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
[TBL] [Abstract][Full Text] [Related]
6. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.
McArdle MJ; deGoma EM; Cohen DL; Townsend RR; Wilensky RL; Giri J
J Am Heart Assoc; 2015 Mar; 4(3):e001415. PubMed ID: 25801757
[No Abstract] [Full Text] [Related]
7. Renal failure after renal sympathetic ablation in a patient with chronic kidney disease--which came first, the chicken or the egg?
Schneider S; Baumann M; Lefeldt S; Laugwitz KL; Heemann U
Int J Cardiol; 2013 Sep; 167(6):e177-8. PubMed ID: 23647587
[No Abstract] [Full Text] [Related]
8. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
Hering D; Esler MD; Schlaich MP
EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
[TBL] [Abstract][Full Text] [Related]
9. Resistant hypertension: is renal denervation the current treatment of choice?
Reddi AS
Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
[TBL] [Abstract][Full Text] [Related]
10. Effects of renal sympathetic denervation in left ventricular hypertrophy in CKD refractory hypertensive patients.
Kiuchi MG; Graciano ML; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Lugon JR
Int J Cardiol; 2016 Jan; 202():121-3. PubMed ID: 26386937
[No Abstract] [Full Text] [Related]
11. [Renal artery denervation for treating refractory hypertension].
Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
[TBL] [Abstract][Full Text] [Related]
12. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices.
Versaci F; Nardi S; Trivisonno A; Olivieri C; Caranci F; Prati F
Int J Cardiol; 2014 Aug; 175(2):370-1. PubMed ID: 24820742
[No Abstract] [Full Text] [Related]
13. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.
Mahfoud F; Cremers B; Janker J; Link B; Vonend O; Ukena C; Linz D; Schmieder R; Rump LC; Kindermann I; Sobotka PA; Krum H; Scheller B; Schlaich M; Laufs U; Böhm M
Hypertension; 2012 Aug; 60(2):419-24. PubMed ID: 22733462
[TBL] [Abstract][Full Text] [Related]
14. Effect of renal denervation on kidney function in patients with chronic kidney disease.
Hering D; Marusic P; Duval J; Sata Y; Head GA; Denton KM; Burrows S; Walton AS; Esler MD; Schlaich MP
Int J Cardiol; 2017 Apr; 232():93-97. PubMed ID: 28089459
[TBL] [Abstract][Full Text] [Related]
15. Renal nerve ablation for hypertensive patients with chronic kidney disease.
Papademetriou V; Doumas M; Anyfanti P; Faselis C; Kokkinos P; Tsioufis C
Curr Vasc Pharmacol; 2014 Jan; 12(1):47-54. PubMed ID: 23905594
[TBL] [Abstract][Full Text] [Related]
16. Renal sympathetic denervation in patients with hypertension and chronic kidney disease: does improvement in renal function follow blood pressure control?
Kiuchi MG; Chen S; Andrea BR; Kiuchi T; Carreira MA; Graciano ML; Lugon JR
J Clin Hypertens (Greenwich); 2014 Nov; 16(11):794-800. PubMed ID: 25293878
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional guided renal denervation: Carrying coals to Newcastle?
Xiao Y; Dong B; Long D; Zhou S; Liu Q
Int J Cardiol; 2015; 187():545-6. PubMed ID: 25863299
[No Abstract] [Full Text] [Related]
18. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
[TBL] [Abstract][Full Text] [Related]
19. Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation.
Linz D; Hohl M; Schütze J; Mahfoud F; Speer T; Linz B; Hübschle T; Juretschke HP; Dechend R; Geisel J; Rütten H; Böhm M
Am J Hypertens; 2015 Feb; 28(2):256-65. PubMed ID: 25023205
[TBL] [Abstract][Full Text] [Related]
20. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.
Vink EE; Verloop WL; Siddiqi L; van Schelven LJ; Liam Oey P; Blankestijn PJ
Int J Cardiol; 2014 Sep; 176(1):8-12. PubMed ID: 25027168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
